Health and environmental impacts of a fertilizer plant--Part II: assessment of radiation exposure.

J Environ Radioact

Interdepartment Centre for Research in Environmental Science, University of Bologna, via dell'Agricoltura 5, 48100 Ravenna, Italy.

Published: September 2005

In the previous paper the authors have studied the radioactive pollution caused by a complex fertilizers production plant. In this paper, the effective doses to the plant workers and to members of the population surrounding the industrial site are estimated. The authors have considered external irradiation, inhalation and ingestion of dust and inhalation of radon and radon daughters as the main occupational exposure routes. After estimating the single contributions, the total effective dose has been calculated as the sum of said contributions. Calculations have been differentiated according to the different tasks of the company employees. The estimated annual effective doses range from 0.6 to 1.4 mSv y(-1). Annual individual effective doses to local residents, resulting from internal and external irradiation caused by particulate matter emitted into the atmosphere by the plant have been estimated. The maximum individual dose rate is estimated to be about 4 microSv y(-1).

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jenvrad.2004.11.008DOI Listing

Publication Analysis

Top Keywords

effective doses
12
external irradiation
8
health environmental
4
environmental impacts
4
impacts fertilizer
4
fertilizer plant--part
4
plant--part assessment
4
assessment radiation
4
radiation exposure
4
exposure previous
4

Similar Publications

Background: Nonalcoholic steatohepatitis (NASH) is a severe form of nonalcoholic fatty liver disease (NAFLD) characterized by damage and inflammation of hepatocytes. Some medicinal plants have shown antioxidant and anti-inflammatory effects on liver cells. We aimed to investigate the hepatoprotective effect of Heptex® capsules containing 200 mg of Dukung Anak (a powdered extract from aerial parts of Phyllanthus niruri) and 100 mg of Milk Thistle (a powdered extract from fruits of Silybum marianum) in patients with an apparent risk factor for NASH.

View Article and Find Full Text PDF

Background: The COVID-19 pandemic has highlighted the need for more effective immunization programs, including in limited resource settings. This paper presents outcomes and lessons learnt from a COVID-19 vaccination campaign (VC), which used a tailored adaptive strategy to optimise vaccine uptake in the Boeny region of Madagascar.

Methods: Guided by the Dynamic Sustainability Framework (DSF), the VC implementation was regularly reviewed through multi-sectoral stakeholder feedback, key informant interviews, problem-solving meetings, and weekly monitoring of outcome indicators to identify and apply key adaptations.

View Article and Find Full Text PDF

Background: Each of the Coronavirus disease 2019 (COVID-19) vaccines has its characteristics that can affect their effectiveness in preventing hospitalization and patient mortality. The present study aimed to determine the effectiveness of COVID-19 vaccines, including whole-virus, protein-based, and vector-based on COVID-19 infection, hospitalization, and mortality.

Methods: The current cohort study was conducted using the data of all people who received at least two doses of each type of COVID-19 vaccine from March 2020 to August 2022 in Khorasan Rzavi province.

View Article and Find Full Text PDF

Long dsRNA induces the expression of type I interferons (IFNs) and IFN-stimulated genes (ISGs) to establish an antiviral state. When induced prophylactically, this antiviral state can reduce the severity and mortality of viral infections. One of the limiting factors in delivering dsRNA in animal models is the lack of an effective carrier that protects the dsRNA from degradation in the extracellular space.

View Article and Find Full Text PDF

Antibody-drug conjugates (ADCs) are an emerging strategy in cancer therapy, enhancing precision and efficacy by linking targeted antibodies to potent cytotoxic agents. This study introduces a novel ADC that combines ribonuclease A (RNase A) with cetuximab (Cet), an anti-EGFR monoclonal antibody, through a polyethylene glycol (PEG) linker (RN-PEG-Cet), aimed to induce apoptosis in KRAS mutant colorectal cancer (CRC) via a ROS-mediated pathway. RN-PEG-Cet was successfully synthesized and characterized for its physicochemical properties, retaining full enzymatic activity in RNA degradation and high binding affinity to EGFR.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!